Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jay Moorin currently holds 1,242,031 shares of EAGLE PHARMACEUTICALS, INC. (EGRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jay Moorin has been a net seller of EGRX stock. They have purchased $10.8M and sold $21.1M worth of shares.
Jay Moorin's most recent insider trade was on Nov 28, 2017, when they sold 177,807 shares at $40.51 per share.
Jay Moorin serves as Executive at EAGLE PHARMACEUTICALS, INC. (EGRX). They have executed 75 insider transactions totaling $31.9M over their tenure at the company.
Jay Moorin holds the position of Executive at EAGLE PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Jay Moorin has shown a selling trading pattern, with $10.8M in total purchases and $21.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jay Moorin was on Nov 28, 2017, when they sold $7.2M worth of URGN shares. This transaction involved 177,807 shares at $40.51 per share.
Jay Moorin currently owns 1,242,031 shares of EAGLE PHARMACEUTICALS, INC. (EGRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jay Moorin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jay Moorin has 75 Form 4 filings on record as an insider at EAGLE PHARMACEUTICALS, INC..
Set alerts for Jay Moorin and 40,000+ other insiders.